| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/21/2001 | CN1288457A Inhibitors of & alpha; 4 mediated cell adhesion |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6203729 Photochromic compounds; for use in ophthalmic and/or solar glasses, lenses, glazing, devices |
| 03/20/2001 | CA2071529C Diaromatic substituted anti-aids compounds |
| 03/20/2001 | CA2019798C Fucosidase inhibitors |
| 03/15/2001 | WO2001017972A2 Novel herbicides |
| 03/15/2001 | WO2001017563A2 Integrin-mediated drug targeting |
| 03/15/2001 | WO2000075127A8 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 03/15/2001 | WO2000058286A3 Method of producing heterocyclic carbamates from aza-heterocyclic compounds and carbon dioxide |
| 03/15/2001 | US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 03/15/2001 | DE10017460A1 Verfahren zur Herstellung von Hexahydrothieno(3,4-d)imidazol-2,4-dionen A process for preparing hexahydrothieno (3,4-d) imidazole-2,4-diones |
| 03/15/2001 | CA2383981A1 Integrin-mediated drug targeting |
| 03/14/2001 | EP1082321A1 Heterocyclic derivatives which inhibit factor xa |
| 03/13/2001 | US6201005 Method for inhibiting lymphokine production |
| 03/13/2001 | US6201004 Dioxino derivatives and their use as therapeutic agents |
| 03/13/2001 | US6200932 As pesticide and herbicide |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016130A1 Substituted indolinones as tyrosine kinase inhibitors |
| 03/08/2001 | CA2381821A1 Substituted indolinones, their manufacture and their use as medicaments |
| 03/07/2001 | EP1081138A1 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds |
| 03/07/2001 | EP1081136A1 Optically active tetrahydrobenzindole derivatives |
| 03/07/2001 | EP1080726A1 Agents for relieving side effects |
| 03/07/2001 | EP0915935B1 4,7-dichlororhodamine dyes |
| 03/07/2001 | EP0730579B1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 03/07/2001 | CN1286690A Compounds useful for inhibition of farnesyl protein transferase |
| 03/07/2001 | CN1286685A Heterocyclic cytotoxic agents |
| 03/07/2001 | CN1286683A Tetrahydrobenzindole derivs |
| 03/07/2001 | CN1286255A Pyridine compounds, their preparation method and pharmaceutical compositions contg them |
| 03/06/2001 | US6197958 Carboxylic acid derivatives, their preparation and use |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 03/06/2001 | US6197225 Chromene compound |
| 03/06/2001 | CA2183655C 4-polycyclic amino-substituted quinazoline derivatives |
| 03/01/2001 | WO2001014386A1 Novel isoindole derivatives |
| 03/01/2001 | WO2001014385A1 Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 03/01/2001 | WO2001014384A1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 03/01/2001 | WO2001014380A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/01/2001 | WO2001014376A1 Novel spiro compounds |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001013950A1 Percutaneous absorption agents |
| 03/01/2001 | WO2001013900A2 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 03/01/2001 | DE19940829A1 New 3-(anilino-methylidene)-2-indolinone derivatives, are kinase inhibitors and cell proliferation inhibitors, useful e.g. for treating tumors, metastasis, rheumatoid arthritis or psoriasis |
| 03/01/2001 | CA2383252A1 Treatment of cardiovascular related pathologies |
| 03/01/2001 | CA2382528A1 Novel isoindole derivatives |
| 03/01/2001 | CA2382418A1 Dihydrobenzofuran derivatives, process for preparing thereof and agents |
| 03/01/2001 | CA2382413A1 Tricyclic dihydrobenzofuran derivatives, process for preparing thereof and agent |
| 03/01/2001 | CA2381468A1 Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 02/28/2001 | EP1078928A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/28/2001 | EP1078926A1 Pyran derivatives |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077967A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077705A1 Potassium channel agonists |
| 02/28/2001 | EP1077698A1 Metabolites of ecteinascidin 743 |
| 02/28/2001 | CN1285835A Novel substituted phenyl keto enols |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/27/2001 | US6194579 Providing quantity of 7-keto camptothecin; selectively substituting leaving group at c7 carbon of 7-keto camptothecin; selectively derivatizing c7 carbon |
| 02/27/2001 | US6194451 Prevent release tumor necrosis factor; antiinflammatory agents |
| 02/27/2001 | US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 02/27/2001 | US6194423 Fused isoquinolines as dopamine receptor ligands |
| 02/27/2001 | US6194409 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/27/2001 | US6194405 3,3a,8,12b-tetrahydro-n-methyl-2h-dibenzo(3,4:6,7)-cyclohepta( 1,2-b)-furan-2-methanamine, for example; anxiolytic agents, antidepressants, sleep and sexual disorders, psychological, cardiovascular and gastrointestinal disorders |
| 02/27/2001 | US6194404 Process for the isolation of galanthamine |
| 02/27/2001 | CA2317053A1 New pyridine derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 02/27/2001 | CA2111204C Piperidine derivatives having anxiolytic effect |
| 02/22/2001 | WO2001012607A2 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | WO2001012602A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/22/2001 | WO2001012197A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 02/22/2001 | WO2001012196A1 Pyridomorphinans and use thereof |
| 02/22/2001 | WO2001011968A2 Heterocyclic spiro compounds as pesticides |
| 02/22/2001 | WO2001011966A1 Fungicides |
| 02/22/2001 | WO2000078724A3 Imidazolinderivatives their preparation and their pharmaceutical use |
| 02/22/2001 | CA2381968A1 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 02/22/2001 | CA2380814A1 Pyridomorphinans, thienomorphinans and use thereof |
| 02/22/2001 | CA2377637A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/21/2001 | CN1284956A Novel bispidine antiarrhythmic compounds |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/20/2001 | US6191279 Dipyrano-quinolinones useful as anti viral agents and a process for preparing the same |
| 02/20/2001 | US6191278 Water-soluble rhodamine dyes and conjugates thereof |
| 02/20/2001 | US6191170 Benzenesulfonamides and benzamides as therapeutic agents |
| 02/20/2001 | US6191140 Potassium channel modulators; muscle relaxants; controlling cell membranes |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/14/2001 | EP1076057A1 Febrifugine and isofebrifugine and processes for the preparation of both |
| 02/14/2001 | EP1075477A1 Novel n-oxides |
| 02/14/2001 | EP1075465A1 Arylphenyl-substituted cyclic keto enols |
| 02/14/2001 | EP0853624B1 Process for the preparation of galanthamine and its derivatives |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 02/14/2001 | EP0773964B1 Gas phase production of polydienes |
| 02/14/2001 | CN1284079A Novel compounds |
| 02/14/2001 | CN1284070A Alicyclic acylated heterocyclic derivatives |
| 02/14/2001 | CN1061977C Aryl substituted heterocycles |
| 02/13/2001 | US6187928 Treating fungal diseases |
| 02/13/2001 | US6187926 Process for producing quinolone derivatives |
| 02/13/2001 | US6187789 Muscle relaxants for emergency intubation and surgery |
| 02/13/2001 | US6187786 Antitumor and anticarcinogenic agents |
| 02/13/2001 | US6187783 Antitumor agents |